Spinnaker Opportunities Plc announced the appointment of Zahid Latif a new retained adviser with cannabis industry experience, the departure of a director and a business update. Zahid originally qualified in pharmaceutical sciences, specializing in natural product chemistry before embarking on a career in industry. He has served as Head of Healthcare at Innovate UK (Technology Strategy Board), a former Board Member of the Cell and Gene Therapy Catapult and Director of Population and Early Detection Research at Cancer Research UK. Currently he undertakes consultancy work and has a role as a Sector Specialist for the Department for International Trade. The role of the Retained Adviser is to advise the Board on a discretionary, part-time consultancy basis as the Board assesses potential Acquisitions. In common with the Directors, Retained Advisers will not receive any fees for their ordinary duties prior to the completion of an Acquisition transaction. Jonathan was one of the founding directors of Spinnaker and has served as its Finance Director. His accounting firm, Welbeck & Associates, is in the process of merging with a larger international firm. In order to mitigate a possible future client conflict, Jonathan has asked to stand down prior to completion of the merger. Jonathan's duties as Finance Director will be taken on by fellow director Alan Hume and his numerical replacement on the board will be named in due course. Jonathan's resignation is effective as of December 06, 2018.